statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

geneType Expands Reach to Canada and New Zealand

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited, under its brand geneType, is ramping up its global expansion by...

Empowering Women's Health with Genomic Knowledge

Genetic Technologies Limited (AU:GTG) has released an update. Genetic Technologies Limited, in partnership with Humanise Health, is set to host 'Kn...

Genetic Technologies reports impact of new digital strategy

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market

MELBOURNE, Australia, April 02, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company , GTG ), a global leader in genomics-based tests in health, wellness and...

Syncona Ltd to Acquire Applied Genetic Technologies Corp Call Transcript

Genetic Technologies collaborations, innovation update

GTG Global Collaborations and Innovation Update

MELBOURNE, Australia, March 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company , GTG ), a global leader in genomics-based tests in health, wellness and...

GENE to develop Worlds Most Advanced Comprehensive Risk Test  Revolutionising Personalised Healthcare

MELBOURNE, Australia, March 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, Company , GENE ), a global leader in guideline-driven genomics-based testing in health...

Genetic Technologies announces 'company's most advanced risk assessment test'

Critical Contrast: Genetic Technologies (NASDAQ:GENE) versus Repligen (NASDAQ:RGEN)

Genetic Technologies (NASDAQ:GENE  Get Free Report) and Repligen (NASDAQ:RGEN  Get Free Report) are both medical companies, but which is the better business? We will contrast the two...

Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through ,the EasyDNA, AffinityDNA, and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

Volume	68,761.00
52-Wk High	$4.65
52-Wk Low	$0.75

GENE Genetic Technologies Ltd.

About

Feed

News

Sentiment

Fundamentals